Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Early Complications and Mortality following Radical Cystectomy: Associations with Malnutrition and Obesity
Hanson, Kristine T. , Habermann, Elizabeth B. , Tollefson, Matthew K. , Habermann, Elizabeth , Arora, Karan , Psutka, Sarah P. , Hanson, Kristine

Mayo Clinic

Bladder Cancer | September 29, 2018 | Volume: 4 | Issue: 4 | Pages: 377-388

10.3233/blc-180173 | PMID 30417048 Get It

Background: There are conflicting data regarding the impact of obesity on postoperative outcomes following radical cystectomy (RC) and how obesity and malnutrition interact in patients undergoing RC. Objective: To evaluate associations of body mass index (BMI), significant preoperative weight loss, and hypoalbuminemia with 30-day complications and mortality after RC. Methods: Review of the American College of Surgeons National Surgical Quality Improvement Program database identified 2,055 patients who underwent RC (2006-12). Univariate and multivariable logistic regression models were developed to assess associations between hypoalbuminemia (<3.5 g/dL), >10% preoperative weight loss, obesity as characterized by BMI (class I: 30–34.9, II: 35–39.9, III: ≥40 kg/m 2 ), and 30-day complications and mortality. Results: The median BMI of the study cohort was 27.82 kg/m 2 with 22.4% classified as having class I, 7.5% class II, and 4.2% class III obesity, respectively. Hypoalbuminemia and >10% weight loss were present in 16.7% and 3.5%, respectively. Among obese patients, 13.4% had hypoalbuminemia. On multivariable analysis, class I (OR 1.43, p = 0.01), class II (OR 1.92, p < 0.001), and class III (OR 2.32, p < 0.001) obesity and hypoalbuminemia (OR 1.47, p = 0.02) were independently associated with 30-day complications, and class III obesity (OR 2.96, p = 0.02) and hypoalbuminemia (OR 2.33, p = 0.03) were independently associated with 30-day mortality. Conclusion: Increasing class of obesity and hypoalbuminemia were independently associated with increased complications following RC. Hypoalbuminemia and class III obesity were associated with early mortality. This study highlights the fact that malnutrition may coexist in obese patients and underscores the need to identify patients with malnutrition who may be candidates for preoperative nutritional optimization.
Pilot Survey of Female Anesthesiologists’ Childbearing and Parental Leave Experiences
Pearson, Amy C. S. , Dodd, Sarah E. , Kraus, Molly B. , Ligda, Kristin M. Ondecko, Hertzberg, Linda B., Patel, Perene V., Chandrabose, Rekha K. , Pearson, Amy C S , Kraus, Molly B , Ligda, Kristin Ondecko

Mayo Clinic

Anesthesia & Analgesia | September 29, 2018 | Volume: 128 | Issue: 6 | Pages: e109-e112

10.1213/ane.0000000000003802 | PMID 31094811 Get It

While the literature regarding physicians’ childbearing experiences is growing, there are no studies documenting those of anesthesiologists. We surveyed a convenience sample of 72 female anesthesiologists to obtain pilot data. Sixty-six women completed the survey (91.7% response rate), reporting 113 total births from before 1990 to present. Of all birth experiences, proportions of respondents reporting parental leave, lactation facilities, and lactation duration as adequate were 52.3%, 45.2%, and 58.3%, respectively. Most mothers (51.8%) gave birth to their first child while they were trainees. The majority (94.9%) favored an official statement supporting parental leave. These results may serve as groundwork for larger studies.
UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice
Liu, Qiuying , Hu, Wenqian , Jeon, Haeseung, Johnson, Sarah H. , Vasmatzis, George , May, Danielle G. , Roux, Kyle J. , Galardy, Paul J. , Hu, Wenqian , Galardy, Paul J , May, Danielle G , Roux, Kyle J , Hussain, Sajjad, Bedekovics, Tibor , Jeon, Haeseung

Mayo Clinic

Blood | September 26, 2018 | Volume: 132 | Issue: 24 | Pages: 2564-2574

10.1182/blood-2018-05-848515 | PMID 30257881 Get It

Abstract The mechanistic target of rapamycin (mTOR) is a central regulator of cellular proliferation and metabolism. Depending on its binding partners, mTOR is at the core of 2 complexes that either promote protein biosynthesis (mTOR complex 1; mTORC1) or provide survival and proliferation signals (mTORC2). Protein biosynthesis downstream of mTORC1 plays an important role in MYC-driven oncogenesis with translation inhibitors garnering increasing therapeutic attention. The germinal center B-cell oncogene UCHL1 encodes a deubiquitinating enzyme that regulates the balance between mTOR complexes by disrupting mTORC1 and promoting mTORC2 assembly. While supporting mTORC2-dependent growth and survival signals may contribute to its role in cancer, the suppression of mTORC1 activity is enigmatic, as its phosphorylation of its substrate 4EBP1 promotes protein biosynthesis. To address this, we used proximity-based proteomics to identify molecular complexes with which UCH-L1 associates in malignant B cells. We identified a novel association of UCH-L1 with the translation initiation complex eIF4F, the target of 4EBP1. UCH-L1 associates with and promotes the assembly of eIF4F and stimulates protein synthesis through a mechanism that requires its catalytic activity. Because of the importance of mTOR in MYC-driven oncogenesis, we used novel mutant Uchl1 transgenic mice and found that catalytic activity is required for its acceleration of lymphoma in the Eμ-myc model. Further, we demonstrate that mice lacking UCH-L1 are resistant to MYC-induced lymphomas. We conclude that UCH-L1 bypasses the need for mTORC1-dependent protein synthesis by directly promoting translation initiation, and that this mechanism may be essential for MYC in B-cell malignancy.
Use of Mate-Pair Sequencing (MPseq) to Elucidate a Complex BCR-ABL1 Rearrangement Observed in a Newly Diagnosed Case of Chronic Myeloid Leukemia
Aguirre, Jose Jara, Hoppman, Nicole L., Vasmatzis, George , Smadbeck, James B. , Johnson, Sarah H. , Smoley, Stephanie A., Pitel, Beth A. , Pitel, Beth A , Baughn, Linda B. , Greipp, Patricia T. , Ketterling, Rhett P. , Peterson, Jess F.

Mayo Clinic

American Journal of Clinical Pathology | September 21, 2018 | Volume: 150 | Issue: suppl_1 | Pages: S131-S132

10.1093/ajcp/aqy102.314 Get It

Population health challenges in primary care: What are the unfinished tasks and who should do them?
North, Frederick , Tulledge‐Scheitel, Sidna M. , Matulis, John C. , Pecina, Jennifer L. , Franqueira, Andrew , Johnson, Sarah S, Chaudhry, Rajeev , Franqueira, Andrew M, Pecina, Jennifer

Mayo Clinic

SAGE Open Medicine | September 18, 2018 | Volume: 6 | Issue: No issue available | Pages: No page available

10.1177/2050312118800209 | PMID 30245819 Get It

Background: There are numerous recommendations from expert sources that help guide primary care providers in cancer screening, infectious disease screening, metabolic screening, monitoring of drug levels, and chronic disease management. Little is known about the potential effort needed for a healthcare system to address these recommendations, or the patient effort needed to complete the recommendations. Methods: For 73 recommended population healthcare items, we examined each of 28,742 patients in a primary care internal medicine practice to determine whether they were up-to-date on recommended screening, immunizations, counseling, and chronic disease management goals. We used a rule-based software tool that queries the medical record for diagnoses, dates, laboratory values, pathology reports, and other information used in creating the individualized recommendations. We counted the number of uncompleted recommendations by age groups and examined the healthcare staff needed to address the recommendations and the potential patient effort needed to complete the recommendations. Results: For the 28,742 patients, there were 127,273 uncompleted recommendations identified for population health management (mean recommendations per patient 4.36, standard deviation of 2.65, range of 0–17 recommendations per patient). The age group with the most incomplete recommendations was age of 50–65 years with 5.5 recommendations per patient. The 18–35 years age group had the fewest incomplete recommendations with 2.6 per patient. Across all age groups, initiation of these recommendations required high-level input (physician, nurse practitioner, or physician’s assistant) in 28%. To completely adhere to recommended services, a 1000-patient cross-section cohort would require a total of 464 procedures and 1956 lab tests. Conclusion: Providers and patients face a daunting number of tasks necessary to meet guideline-generated recommendations. We will need new approaches to address the burgeoning numbers of uncompleted recommendations.
International Analysis of LVAD Point-of-Care Versus Plasma INR: A Multicenter Study
Schettle, Sarah , Schlöglhofer, Thomas , Zimpfer, Daniel , Salimbangon, A., Wolforth, Jennifer, Schroeder, Sarah E. , Hards, Rachel, Ritchie, Brianne M., Staley, Linda L., Pereira, Naveen L. , Kushwaha, Sudhir S. , Maltais, Simon, Stulak, John M., Ritchie, Brianne, Staley, Linda, Kushwaha, Sudhir, Schima, Heinrich , Kaufmann, Friedrich , Zimpfer, Daniel

Mayo Clinic

ASAIO Journal | September 8, 2018 | Volume: 64 | Issue: 6 | Pages: e161-e165

10.1097/mat.0000000000000845 | PMID 30199385 Get It

International normalized ratio (INR) measurements manage risks of bleeding and clotting sequelae in the population with left ventricular assist device (LVAD). Studies suggest that point-of-care (POC) INR does not significantly differ from plasma INR (P-INR) values in other patient populations, although this has not been validated in a multicenter LVAD study. We sought to determine whether POC-INR and P-INR values differ significantly in the LVAD population and reviewed patients with permanent LVAD implantation at seven institutions internationally. Our cohort comprised of 279 paired POC-INR and P-INR checks in patients supported on average 630 ± 598 days postimplant with predominately HeartWare, HeartMate II, and HeartMate III devices. The population averaged 57.9 years of age, and there were 86.7% male. We found no statistically significant difference between POC-INR and P-INR values. International normalized ratio accuracy correlated weakly with the time between INR measurements (p < 0.001). When the time difference was less than 4 hours, the difference between INR pairs was significantly lower than measurements greater than 8 hours (p = 0.006). There was no statistically significant difference when comparing paired INR values and time after implant to INR check (p = 0.43), age (p = 0.12), known coagulopathy (p = 0.12), bleeding history (p = 0.22), or thrombosis history (p = 0.34). This is the first large multicenter international study comparing POC-INR and P-INR measurements in patients with LVAD and found no statistically significant difference between either methods, particularly when measured within less than 4 hours of each other.
Thoracogenic spinal deformity: a rare cause of early-onset scoliosis
Eby, Sarah F. , Hilaire, Tricia St., Glotzbecker, Michael P. , Smith, John T. , White, Klane K. , _, _, Larson, A. Noelle , _, _

Mayo Clinic

Journal of Neurosurgery: Spine | September 7, 2018 | Volume: 29 | Issue: 6 | Pages: 674-679

10.3171/2018.4.spine171389 | PMID 30192221 Get It

OBJECTIVESurgery for severe congenital defects, such as congenital diaphragmatic hernia, congenital heart defects, and tracheoesophageal disorders, are life-saving treatments for many infants. However, the incidence of scoliosis following thoracoabdominal surgery has been reported to range from 8% to 50%. Little is known about severe scoliosis that occurs after chest wall procedures in infants. The authors sought to determine the prevalence of thoracogenic scoliosis, disease severity, and need for scoliosis surgery in patients who underwent chest wall procedures in early childhood.METHODSA multicenter database of patients with early-onset scoliosis was queried to identify patients with a history of thoracogenic or acquired iatrogenic scoliosis. Patients with significant congenital spine deformities were excluded. Forty-one patients (1.6%) were noted to have thoracogenic scoliosis. Of these patients, 14 patients were observed; 10 received casts and/or braces; and 17 underwent treatment with rib-based distraction rods, Shilla procedures, or spine-based growing rod devices. Radiographs, complications, and patient characteristics were reviewed.RESULTSThe mean age at scoliosis diagnosis for the 41 patients was 6.0 years. The mean time to follow-up was 2.9 years (4.5 years in the 17 surgical patients). The mean preoperative coronal Cobb angle in the surgical group was 65° and improved to 47° postoperatively (p = 0.01). The mean Cobb angle for the nonoperative group was 31° initially and 32° at follow-up (p = 0.44). Among the 17 patients undergoing surgery for scoliosis, there were 13 complications in 7 patients, including a brachial plexus palsy following rib-based distraction rod placement. This resolved with revision of the rib hooks. There were no known complications in the nonoperative cohort.CONCLUSIONSSevere scoliosis can develop after thoracoabdominal surgeries during infancy. Further work is needed to understand the pathogenesis of scoliosis in this population so as to implement measures for prevention and early diagnosis and to guide appropriate treatment.
Ibrutinib (I) plus bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a 2-year follow-up of the HELIOS study.
Fraser, Graeme , Silva, Rodrigo Santucci, Pylypenko, Halyna, Janssens, Ann , Pristupa, Aleksander, Mayer, Jiřı́ , Dilhuydy, Marie‐Sarah, Loscertales, Javier, Avigdor, Abraham , Rule, Simon , Phelps, Charles E. , Mahler, Michelle, Salman, Mariya, Howes, Angela, Balasubramanian, Sriram , Chanan‐Khan, Asher , Cramer, Paula , Demırkan, Fatih , Grosicki, Sebastian , Goy, Andre Henri

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7525-7525

10.1200/jco.2016.34.15_suppl.7525 Get It

Acute care use among women receiving adjuvant chemotherapy for breast cancer.
Ruddy, Kathryn J. , Sangaralingham, Lindsey R. , Jemal, Ahmedin , Thompson, Carrie A. , Hashmi, Shahrukh K. , Mougalian, Sarah S. , Gross, Cary P. , Shah, Nilay D. , Freedman, Rachel A.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 6543-6543

10.1200/jco.2016.34.15_suppl.6543 Get It